603456 Stock Overview
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.36 |
52 Week High | CN¥34.99 |
52 Week Low | CN¥14.88 |
Beta | 0.12 |
1 Month Change | -23.62% |
3 Month Change | -26.22% |
1 Year Change | -55.09% |
3 Year Change | -64.73% |
5 Year Change | 77.37% |
Change since IPO | 148.86% |
Recent News & Updates
Shareholder Returns
603456 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -6.5% | -4.2% | -4.9% |
1Y | -55.1% | -19.0% | -21.1% |
Return vs Industry: 603456 underperformed the CN Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: 603456 underperformed the CN Market which returned -21.1% over the past year.
Price Volatility
603456 volatility | |
---|---|
603456 Average Weekly Movement | 6.7% |
Pharmaceuticals Industry Average Movement | 7.7% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.4% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603456's share price has been volatile over the past 3 months.
Volatility Over Time: 603456's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 4,877 | Lirong Hua | www.jiuzhoupharma.com |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Fundamentals Summary
603456 fundamental statistics | |
---|---|
Market cap | CN¥13.82b |
Earnings (TTM) | CN¥1.03b |
Revenue (TTM) | CN¥5.52b |
13.4x
P/E Ratio2.5x
P/S RatioIs 603456 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603456 income statement (TTM) | |
---|---|
Revenue | CN¥5.52b |
Cost of Revenue | CN¥3.52b |
Gross Profit | CN¥2.00b |
Other Expenses | CN¥965.80m |
Earnings | CN¥1.03b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 1.15 |
Gross Margin | 36.19% |
Net Profit Margin | 18.71% |
Debt/Equity Ratio | 4.7% |
How did 603456 perform over the long term?
See historical performance and comparison